LGBT Cancer Project

Ovarian Cancer Clinical Trials

A listing of Ovarian Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alaska

UPDATED

Anchorage Alaska 99508

Patients are needed to participate in a clinical research study evaluating cediranib and olaparib for the treatment of Recurrent Platinum Resistant Ovarian Cancer

California

UPDATED

Downey California 90241

Patients are needed to participate in a clinical research study evaluating cediranib and olaparib for the treatment of Recurrent Platinum Resistant Ovarian Cancer

UPDATED

Fullerton California 92835

Patients are needed to participate in a clinical research study evaluating cediranib and olaparib for the treatment of Recurrent Platinum Resistant Ovarian Cancer

UPDATED

Greenbrae California 94904

Patients are needed to participate in a clinical research study evaluating cediranib and olaparib for the treatment of Recurrent Platinum Resistant Ovarian Cancer

UPDATED

Los Angeles California 90048

Patients are needed to participate in a clinical research study evaluating cediranib and olaparib for the treatment of Recurrent Platinum Resistant Ovarian Cancer

UPDATED

Orange California 92868-3298

Patients are needed to participate in a clinical research study evaluating cediranib and olaparib for the treatment of Recurrent Platinum Resistant Ovarian Cancer

UPDATED

San Diego California 92123

Patients are needed to participate in a clinical research study evaluating cediranib and olaparib for the treatment of Recurrent Platinum Resistant Ovarian Cancer

Florida

UPDATED

Miami Florida 33143

Patients are needed to participate in a clinical research study evaluating cediranib and olaparib for the treatment of Recurrent Platinum Resistant Ovarian Cancer

UPDATED

Orlando Florida 32804-4674

Patients are needed to participate in a clinical research study evaluating cediranib and olaparib for the treatment of Recurrent Platinum Resistant Ovarian Cancer

UPDATED

West Palm Beach Florida 33401

Patients are needed to participate in a clinical research study evaluating cediranib and olaparib for the treatment of Recurrent Platinum Resistant Ovarian Cancer

Georgia

UPDATED

Augusta Georgia 30901

Patients are needed to participate in a clinical research study evaluating cediranib and olaparib for the treatment of Recurrent Platinum Resistant Ovarian Cancer

Illinois

UPDATED

Skokie Illinois 60077

Patients are needed to participate in a clinical research study evaluating cediranib and olaparib for the treatment of Recurrent Platinum Resistant Ovarian Cancer

Indiana

UPDATED

Fort Wayne Indiana 46808

Patients are needed to participate in a clinical research study evaluating cediranib and olaparib for the treatment of Recurrent Platinum Resistant Ovarian Cancer

UPDATED

Terre Haute Indiana 47802

Patients are needed to participate in a clinical research study evaluating cediranib and olaparib for the treatment of Recurrent Platinum Resistant Ovarian Cancer

Kansas

UPDATED

Westwood Kansas 66205

Patients are needed to participate in a clinical research study evaluating cediranib and olaparib for the treatment of Recurrent Platinum Resistant Ovarian Cancer

Louisiana

UPDATED

Covington Louisiana 70433-7201

Patients are needed to participate in a clinical research study evaluating cediranib and olaparib for the treatment of Recurrent Platinum Resistant Ovarian Cancer

Maryland

UPDATED

Baltimore Maryland 21204

Patients are needed to participate in a clinical research study evaluating cediranib and olaparib for the treatment of Recurrent Platinum Resistant Ovarian Cancer

UPDATED

Bethesda Maryland 20817-7847

Patients are needed to participate in a clinical research study evaluating cediranib and olaparib for the treatment of Recurrent Platinum Resistant Ovarian Cancer

Massachusetts

UPDATED

Boston Massachusetts 02215

Patients are needed to participate in a clinical research study evaluating cediranib and olaparib for the treatment of Recurrent Platinum Resistant Ovarian Cancer

Minnesota

UPDATED

St. Louis Park Minnesota 55416

Patients are needed to participate in a clinical research study evaluating cediranib and olaparib for the treatment of Recurrent Platinum Resistant Ovarian Cancer

Missouri

UPDATED

Kansas City Missouri 64132

Patients are needed to participate in a clinical research study evaluating cediranib and olaparib for the treatment of Recurrent Platinum Resistant Ovarian Cancer

Montana

UPDATED

Billings Montana 59101

Patients are needed to participate in a clinical research study evaluating cediranib and olaparib for the treatment of Recurrent Platinum Resistant Ovarian Cancer

New Jersey

UPDATED

Bricktown New Jersey 08724

Patients are needed to participate in a clinical research study evaluating cediranib and olaparib for the treatment of Recurrent Platinum Resistant Ovarian Cancer

New York

UPDATED

Lake Success New York 11042

Patients are needed to participate in a clinical research study evaluating cediranib and olaparib for the treatment of Recurrent Platinum Resistant Ovarian Cancer

UPDATED

Rochester New York 14642

Patients are needed to participate in a clinical research study evaluating cediranib and olaparib for the treatment of Recurrent Platinum Resistant Ovarian Cancer

North Carolina

UPDATED

Winston-Salem North Carolina 27103

Patients are needed to participate in a clinical research study evaluating cediranib and olaparib for the treatment of Recurrent Platinum Resistant Ovarian Cancer

Oklahoma

UPDATED

Oklahoma City Oklahoma 73104

Patients are needed to participate in a clinical research study evaluating cediranib and olaparib for the treatment of Recurrent Platinum Resistant Ovarian Cancer

Pennsylvania

UPDATED

Pittsburgh Pennsylvania 15213

Patients are needed to participate in a clinical research study evaluating cediranib and olaparib for the treatment of Recurrent Platinum Resistant Ovarian Cancer

South Dakota

UPDATED

Sioux Falls South Dakota 57105

Patients are needed to participate in a clinical research study evaluating cediranib and olaparib for the treatment of Recurrent Platinum Resistant Ovarian Cancer

Tennessee

UPDATED

Knoxville Tennessee 37920

Patients are needed to participate in a clinical research study evaluating cediranib and olaparib for the treatment of Recurrent Platinum Resistant Ovarian Cancer

Texas

UPDATED

Houston Texas 77030

A Phase 1/Phase 2 clinical study for patients with Malignant Neoplasms of Female Genital Organs, Ovarian Cancer, Primary Peritoneal Carcinoma or Fallopian Tube Cancer

Washington

UPDATED

Seattle Washington 98104

Patients are needed to participate in a clinical research study evaluating cediranib and olaparib for the treatment of Recurrent Platinum Resistant Ovarian Cancer

UPDATED

Tacoma Washington 98415

Patients are needed to participate in a clinical research study evaluating cediranib and olaparib for the treatment of Recurrent Platinum Resistant Ovarian Cancer

Canada

UPDATED

Toronto Ontario M5G 2M9

Patients are needed to participate in a clinical research study of Cyclophosphamide and TBI-1301